We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

77 hedge funds and large institutions have $6.92M invested in Ampio Pharmaceuticals Inc. in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

305% more call options, than puts

Call options by funds: $223K | Put options by funds: $55K

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

1% more funds holding

Funds holding: 76 → 77 (+1)

21% less capital invested

Capital invested by funds: $8.75M → $6.92M (-$1.83M)

Holders
77
Holders Change
+1
Holders Change %
+1.32%
% of All Funds
1.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
17
Reduced
10
Closed
8
Calls
$223K
Puts
$55K
Net Calls
+$168K
Net Calls Change
+$51K

Top Buyers

Rank Fund Capital Flow
1
AAP
Arax Advisory Partners
Colorado
+$1.07M
2
WWM
Western Wealth Management
Colorado
+$463K
3
Group One Trading
Group One Trading
Illinois
+$238K
4
HC
HNP Capital
New York
+$229K
5
Citadel Advisors
Citadel Advisors
Florida
+$85.6K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$606K
2
CH
CVI Holdings
Delaware
-$324K
3
VFA
Valeo Financial Advisors
Indiana
-$318K
4
Renaissance Technologies
Renaissance Technologies
New York
-$83K
5
Millennium Management
Millennium Management
New York
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
Traynor Capital Management
Pennsylvania
$40K +$4.16K +23 +8%
Charles Schwab
27
Charles Schwab
California
$31K – – –
CPIG
28
Chicago Partners Investment Group
Illinois
$28K – – –
DIA
29
Dana Investment Advisors
Wisconsin
$27K +$39.3K +217 New
RJFSA
30
Raymond James Financial Services Advisors
Florida
$25K +$2.9K +16 +9%
GWM
31
Geneos Wealth Management
Colorado
$25K +$9.05K +50 +34%
Victory Capital Management
32
Victory Capital Management
Texas
$22K +$31K +171 New
UCFA
33
United Capital Financial Advisors
Texas
$20K +$905 +5 +3%
HAG
34
HighPoint Advisor Group
Illinois
$19K -$4.16K -23 -16%
State Street
35
State Street
Massachusetts
$19K – – –
Wolverine Trading
36
Wolverine Trading
Illinois
$18K +$25.5K +141 New
JWA
37
JFS Wealth Advisors
Pennsylvania
$15K – – –
MAM
38
Marotta Asset Management
Virginia
$12.7K – – –
SBIA
39
Sheaff Brock Investment Advisors
Indiana
$10K +$15K +83 New
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$9K – – –
Jane Street
41
Jane Street
New York
$9K +$13.4K +74 New
WP
42
WealthPLAN Partners
Nebraska
$8K -$9.05K -50 -51%
MMA
43
Miracle Mile Advisors
California
$8K – – –
Morgan Stanley
44
Morgan Stanley
New York
$8K +$1.27K +7 +12%
Commonwealth Equity Services
45
Commonwealth Equity Services
Massachusetts
$8K +$5.25K +29 +71%
Brown Advisory
46
Brown Advisory
Maryland
$7K – – –
JWM
47
Janiczek Wealth Management
Colorado
$7K – – –
Wells Fargo
48
Wells Fargo
California
$7K +$362 +2 +3%
IWM
49
IHT Wealth Management
Illinois
$7K +$10.1K +56 New
PNC Financial Services Group
50
PNC Financial Services Group
Pennsylvania
$6K – – –
1
2
3 4

AMPE Hedge Fund Activity: Q1 2020 in Review

77 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2020, worth a combined $6.92M — down 21% from $8.75M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new AMPE positions and 8 closed out — a net gain of 4 holders — while 17 added to existing stakes and 10 trimmed.

The largest buyer was Arax Advisory Partners, opening a new position worth an estimated $1.07M. The largest seller was Susquehanna International Group, cutting an estimated $606K.

  • 77 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2020, up from 76 in Q4 2019.
  • Funds reported $6.92M of Ampio Pharmaceuticals Inc. stock for Q1 2020, down 21% quarter-over-quarter.
  • 12 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2020 and 8 closed out, a net change of +4 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2020 was Arax Advisory Partners, an estimated $1.07M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2020 was Susquehanna International Group, an estimated $606K sold.

Based on aggregated 13F filings for Q1 2020.